Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Platform Technology To Speed Up CMC Process Dr H. Fai Poon, President, QuaCell Biotech Ltd The commercial success of monoclonal antibodies has made biologics become attractive to pharmaceutical companies . The approval pathway is often requi... 2 weeks ago | 32 mins Mixed mode Chromatography in Purifying biologics - Overview Vivek Halan Zumutor Biologics Pvt Ltd, Bangalore, India This Webinar will discuss MMC in purifying biologics which includes monoclonal antibodies (mAbs), Bispecific antibodies (BsAbs), antibody fragments (S... 4 years ago | 41 mins Clone Wars: An In Depth Look at Mouse vs Rabbit Antibodies Faris Omary and Leah Hartman Have you ever found yourself wondering which clone of Napsin A to use? What about PAX-8? Or the ongoing dilemma of ordering a mouse monoclonal vs rabb... 3 years ago | 40 mins Single Use Process for Production of AAV Gene Therapy Products Lance Marquardt at PTC Therapeutics, Vikas Gupta, at Repligen, Rachel Legmann at Repligen, and Gilbert Huang at Repligen An overview of single use manufacturing for the production of AAV gene therapy products with comparisons to traditional monoclonal antibody production... 10 months ago | 120 mins CCAB: CCAB: Addressing the risk of microbial impurities... Dr Friedrich von Wintzingerode, QC Lead iNeST, Roche and Nahuel Paolini, PhD, Sanquin Reagents Full Title: CCAB: Addressing the risk of microbial impurities in Biologics and certain Advanced Therapy Medicinal Products (ATMPs) For parenteral dr... 1 year ago | 69 mins A Comprehensive Approach to Assess the Impact of Microbial Impurities on Pat... Dr Friedrich von Wintzingerode, QC Lead iNeST Project at Roche and Shabnam Solati, CEO & Co-Founder at CTL-MAT FULL TITLE: A Comprehensive Approach to Assess the Impact of Microbial Impurities on Patient Safety and Product Quality of Biologics Presented by Dr ... 3 years ago | 80 mins Single-Use & Stainless Steel BioReactors: Quality Factors for Consideration Dr Trevor Deeks, Principal and Consultant of Deeks Pharmaceutical Consulting Services, LLC Single-use (SU) systems are now in common use in pharmaceutical bioprocessing, as well as in other related technologies such as the manufacture of dia... 5 years ago | 76 mins Learn about Laboratory Considerations when Developing Multiple Myeloma Trials Dr. Domenica Gandini, ICON Join ICON’s experts Dr. Marc Golightly, PhD and Domenica Gandini as they speak about considerations when developing Multiple Myeloma trials. With the... 7 years ago | 60 mins Stable Isotope-Labeled Protein Internal Standards James Walters, Ph.D. Mass spectrometry-based protein assays impart increased specificity and more rapid development times versus traditional methods, such as ELISA. Couple... 6 years ago | 62 mins Advances in Mass Spectrometry for the Analysis and Bioanalysis of Antibody-Drug Arnaud Delobel, PhD ADCs are complex compounds resulting from the coupling of cytotoxic small molecules to a monoclonal antibody. Their characterization as well as their ... 6 years ago | 34 mins
